Analysts Expect Immunic (IMUX) Stock to Rise 202%; Rated Strong Buy


Immunic Inc (IMUX) stock has fallen -95.19% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. Stock Score Report, InvestorsObserver’s proprietary scoring system, gives IMUX stock a score of 64 out of a possible 100.

That score is primarily influenced by a fundamental score of 89. In addition to the average rating from Wall Street analysts, IMUX stock has a mean target price of $50.00. This means analysts expect the stock to increase 201.93% over the next 12 months. IMUX’s score also includes a long-term technical score of 58. The short-term technical score for IMUX is 46.

Click Here to get the full Stock Score Report on Immunic Inc (IMUX).

What’s Happening with IMUX Stock Today

Immunic Inc (IMUX) stock is higher by 51.37% while the S&P 500 has fallen -0.06% as of 2:15 PM on Thursday, Jul 11. IMUX has gained $5.62 from the previous closing price of $10.94 on volume of 3,071,251 shares. Over the past year the S&P 500 is higher by 7.07% while IMUX has fallen -95.19%. IMUX lost -$39.16 per share in the over the last 12 months.

Symbols: IMUX

You May Also Like